Compare fluocinolone and dexamethasone implants for resistant eye swelling
Part of Eyes & vision, Hormones & metabolism clinical trials.
This trial looks at which long-acting steroid implant works better for diabetic macular swelling that did not improve enough with past treatments. It may help patients by testing a treatment option aimed at improving vision when other eye injections have not worked well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can give informed consent and you’re an adult
- You have diabetic macular swelling in one or both eyes that’s still present after years of treatment
- Your vision test result is limited (BCVA of 80 letters or less on the ETDRS scale)
- You were treated before: at least one steroid (dexamethasone) injection more than 5 months ago and at least one anti-VEGF injection more than 3 months ago
- Your eye lens situation matches the study: you are pseudophakic (received cataract lens surgery more than 6 months ago)
- Your current eye and health conditions must allow follow-up and make steroid implants safe (for example, no pregnancy, no serious eye infections, and controlled blood sugar)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
This trial tests whether a single steroid injection around the back of the eye can improve vision in people with diabetic macular edema (swelling in the center of the retina that blurs vision). It is for people who have not yet had any other eye treatments for this condition.
This trial tests a more frequent dosing of an eye injection called pegaptanib (Macugen) to see if it can quickly reduce swelling in the retina caused by diabetes and improve vision. It is for people with diabetic macular edema who have some vision loss.
This study tests whether a steroid medication can help reduce swelling in the back of the eye caused by diabetic macular edema, a complication of type 2 diabetes. If you qualify, you may receive this treatment to potentially improve your vision.
This trial tests whether combining a steroid implant (dexamethasone) with an anti-VEGF injection (aflibercept) works better than the injection alone for people with diabetic macular edema who haven't been treated yet. It aims to improve vision and reduce retinal swelling.
This study tests a special contact lens that slowly delivers anti-inflammatory/steroid medicine to the back of the eye. It aims to treat cystoid macular edema that keeps coming back and may improve vision for people who respond to steroid treatment.
Hear when a new Diabetic Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.